{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:42:56Z","timestamp":1787236976422,"version":"build-2736575974"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Metabolic dysfunction-associated fatty liver disease (MAFLD) is a chronic liver disease that progresses from hepatic steatosis to non-alcoholic steatohepatitis, cirrhosis, and liver cancer, posing a huge burden on human health. Existing research has confirmed that forkhead box O1 (FOXO1), as a member of the FOXO transcription factor family, is upregulated in MAFLD. Its activity is closely related to nuclear-cytoplasmic shuttling and various post-translational modifications including phosphorylation, acetylation, and methylation. FOXO1 mediates the progression of MAFLD by regulating glucose metabolism, lipid metabolism, insulin resistance, oxidative stress, hepatic fibrosis, hepatocyte autophagy, apoptosis, and immune inflammation. This article elaborates on the regulatory role of FOXO1 in MAFLD, providing a summary and new insights for the current status of drug research and targeted therapies for MAFLD.<\/jats:p>","DOI":"10.3389\/fnut.2024.1426780","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:33:25Z","timestamp":1719880405000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Forkhead box O1 in metabolic dysfunction-associated fatty liver disease: molecular mechanisms and drug research"],"prefix":"10.3389","volume":"11","author":[{"given":"Xiangjun","family":"Sha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canghai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14218\/JCTH.2020.00082","article-title":"Diversity in NAFLD: a review of manifestations of nonalcoholic fatty liver disease in different ethnicities globally","author":"Han","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1875-5364(20)30017-0","article-title":"Fatty liver diseases, mechanisms, and potential therapeutic plant medicines","volume":"18","author":"Zhu","year":"2020","journal-title":"Chin J Nat Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2478\/bjmg-2022-0006","article-title":"Identification of key target genes and pathway analysis in nonalcoholic fatty liver disease via integrated bioinformatics analysis","volume":"25","author":"Chen","year":"2023","journal-title":"Balkan J Med Genet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/onc.2008.24","article-title":"FOXOs, cancer and regulation of apoptosis","volume":"27","author":"Fu","year":"2008","journal-title":"Oncogene"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41419-023-06177-1","article-title":"FOXO family isoforms","volume":"14","author":"Santos","year":"2023","journal-title":"Cell Death Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.devcel.2010.03.008","article-title":"FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor","volume":"18","author":"Chen","year":"2010","journal-title":"Dev Cell"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1055\/s-0042-105153","article-title":"The transcriptional regulation of FOXO genes in Thyrocytes","volume":"48","author":"Franz","year":"2016","journal-title":"Horm Metab Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1128\/MCB.21.10.3534-3546.2001","article-title":"Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX","volume":"21","author":"Brownawell","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbamcr.2015.10.019","article-title":"FoxO1 mediates TGF-beta1-dependent cardiac myofibroblast differentiation","volume":"1863","author":"Vivar","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells9010184","article-title":"A review of FoxO1-regulated metabolic diseases and related drug discoveries","volume":"9","author":"Peng","year":"2020","journal-title":"Cells"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/acel.12452","article-title":"The FoxO3 gene and cause-specific mortality","volume":"15","author":"Willcox","year":"2016","journal-title":"Aging Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/CIRCRESAHA.107.163428","article-title":"Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors","volume":"102","author":"Evans-Anderson","year":"2008","journal-title":"Circ Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"H1470","DOI":"10.1152\/ajpheart.00838.2020","article-title":"FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K","volume":"320","author":"Weeks","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/hmg\/dds040","article-title":"Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy","volume":"21","author":"Vidal","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.semcancer.2017.09.009","article-title":"FOXO1: another avenue for treating digestive malignancy?","volume":"50","author":"Shi","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.semcancer.2018.01.005","article-title":"FOXOs in cancer immunity: knowns and unknowns","volume":"50","author":"Deng","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bone.2011.06.034","article-title":"FoxO1, the transcriptional chief of staff of energy metabolism","volume":"50","author":"Kousteni","year":"2012","journal-title":"Bone"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.plipres.2017.04.002","article-title":"A global perspective on FOXO1 in lipid metabolism and lipid-related diseases","volume":"66","author":"Li","year":"2017","journal-title":"Prog Lipid Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/tox.23898","article-title":"Circular RNA nuclear receptor interacting protein 1 promoted biliary tract cancer epithelial-mesenchymal transition and stemness by regulating the miR-515-5p\/AKT2 axis and PI3K\/AKT\/mTOR signaling pathway","volume":"38","author":"Gao","year":"2023","journal-title":"Environ Toxicol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"25195","DOI":"10.18632\/aging.203735","article-title":"YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to regulate LRRC1","volume":"13","author":"Guan","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2147\/DDDT.S305016","article-title":"Forkhead box protein O1: functional diversity and post-translational modification, a new therapeutic target?","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI12876","article-title":"The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression","volume":"108","author":"Nakae","year":"2001","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2337\/db05-0678","article-title":"Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell","volume":"55","author":"Martinez","year":"2006","journal-title":"Diabetes"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/s0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"36324","DOI":"10.1074\/jbc.M003616200","article-title":"Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity","volume":"275","author":"Schmoll","year":"2000","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"6331","DOI":"10.1038\/sj.onc.1204777","article-title":"14-3-3 proteins; bringing new definitions to scaffolding","volume":"20","author":"Tzivion","year":"2001","journal-title":"Oncogene"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1042\/0264-6021:3540605","article-title":"Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting","volume":"354","author":"Rena","year":"2001","journal-title":"Biochem J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"17184","DOI":"10.1074\/jbc.274.24.17184","article-title":"Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence","volume":"274","author":"Guo","year":"1999","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/gtc.12226","article-title":"Translocation of forkhead box O1 to the nuclear periphery induces histone modifications that regulate transcriptional repression of PCK1 in HepG2 cells","volume":"20","author":"Arai","year":"2015","journal-title":"Genes Cells"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1074\/jbc.RA119.008649","article-title":"AMPK and AKT protein kinases hierarchically phosphorylate the N-terminus of the FOXO1 transcription factor, modulating interactions with 14-3-3 proteins","volume":"294","author":"Saline","year":"2019","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"35583","DOI":"10.1074\/jbc.M704735200","article-title":"Chromatin opening and stable perturbation of core histone: DNA contacts by FoxO1","volume":"282","author":"Hatta","year":"2007","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbrc.2009.01.014","article-title":"Acetylation curtails nucleosome binding, not stable nucleosome remodeling, by FoxO1","volume":"379","author":"Hatta","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41580-023-00649-0","article-title":"FOXO transcription factors as mediators of stress adaptation","volume":"25","author":"Rodriguez-Colman","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1038\/sj.onc.1207118","article-title":"p300\/CBP and cancer","volume":"23","author":"Iyer","year":"2004","journal-title":"Oncogene"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature07861","article-title":"CBP\/p300-mediated acetylation of histone H3 on lysine 56","volume":"459","author":"Das","year":"2009","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000369718","article-title":"Modulation of SIRT1-Foxo1 signaling axis by resveratrol: implications in skeletal muscle aging and insulin resistance","volume":"35","author":"Sin","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"10042","DOI":"10.1073\/pnas.0400593101","article-title":"Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity","volume":"101","author":"Daitoku","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2008.08.014","article-title":"SirT1 gain of function increases energy efficiency and prevents diabetes in mice","volume":"8","author":"Banks","year":"2008","journal-title":"Cell Metab"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"20589","DOI":"10.1074\/jbc.M412357200","article-title":"Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes","volume":"280","author":"Frescas","year":"2005","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cmet.2007.07.003","article-title":"SIRT2 regulates adipocyte differentiation through FoxO1 acetylation\/deacetylation","volume":"6","author":"Jing","year":"2007","journal-title":"Cell Metab"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.110.227371","article-title":"Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes","volume":"107","author":"Hariharan","year":"2010","journal-title":"Circ Res"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1038\/emboj.2012.97","article-title":"Novel repressor regulates insulin sensitivity through interaction with Foxo1","volume":"31","author":"Nakae","year":"2012","journal-title":"EMBO J"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"27396","DOI":"10.1074\/jbc.M110.140228","article-title":"Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization","volume":"285","author":"Qiang","year":"2010","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"11278","DOI":"10.1073\/pnas.0502738102","article-title":"Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation","volume":"102","author":"Matsuzaki","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/hep.25809","article-title":"Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner","volume":"56","author":"Choi","year":"2012","journal-title":"Hepatology"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cmet.2011.03.017","article-title":"Asymmetric arginine dimethylation determines life span in C. elegans by regulating forkhead transcription factor DAF-16","volume":"13","author":"Takahashi","year":"2011","journal-title":"Cell Metab"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/nar\/gky1230","article-title":"FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer","volume":"47","author":"Chae","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"9636","DOI":"10.1074\/jbc.M109.062588","article-title":"G9a and Glp methylate lysine 373 in the tumor suppressor p53","volume":"285","author":"Huang","year":"2010","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.biochi.2008.03.005","article-title":"O-GlcNAc modification of FoxO1 increases its transcriptional activity: a role in the glucotoxicity phenomenon?","volume":"90","author":"Kuo","year":"2008","journal-title":"Biochimie"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"16283","DOI":"10.1074\/jbc.M802240200","article-title":"O-GlcNAc regulates FoxO activation in response to glucose","volume":"283","author":"Housley","year":"2008","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bbrc.2015.04.114","article-title":"Regulatory O-GlcNAcylation sites on FoxO1 are yet to be identified","volume":"462","author":"Fardini","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1074\/jbc.M808890200","article-title":"A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose","volume":"284","author":"Housley","year":"2009","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"11285","DOI":"10.1073\/pnas.1934283100","article-title":"Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation","volume":"100","author":"Matsuzaki","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/MPA.0000000000001239","article-title":"Menin upregulates FOXO1 protein stability by repressing Skp2-mediated degradation in \u03b2 cells","volume":"48","author":"Jiang","year":"2019","journal-title":"Pancreas"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1073\/pnas.0406789102","article-title":"Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation","volume":"102","author":"Huang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"13987","DOI":"10.1074\/jbc.M901758200","article-title":"MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation","volume":"284","author":"Fu","year":"2009","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1210\/me.2013-1420","article-title":"USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy","volume":"28","author":"Hall","year":"2014","journal-title":"Mol Endocrinol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/nature09599","article-title":"S-glutathionylation uncouples eNOS and regulates its cellular and vascular function","volume":"468","author":"Chen","year":"2010","journal-title":"Nature"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1124\/mi.7.6.7","article-title":"S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response","volume":"7","author":"Townsend","year":"2007","journal-title":"Mol Interv"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2337\/db07-0714","article-title":"Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis","volume":"57","author":"Valenti","year":"2008","journal-title":"Diabetes"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1586\/17474124.2016.1110018","article-title":"The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?","volume":"10","author":"Dongiovanni","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.bbrc.2009.01.163","article-title":"Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway","volume":"380","author":"Wang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1002\/mnfr.201600197","article-title":"\u03b2-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes","volume":"60","author":"Kamikubo","year":"2016","journal-title":"Mol Nutr Food Res"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejphar.2012.07.028","article-title":"Alpha-lipoic acid induces adipose triglyceride lipase expression and decreases intracellular lipid accumulation in HepG2 cells","volume":"692","author":"Kuo","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejphar.2016.06.043","article-title":"Effects of the new thiazolidine derivative LPSF\/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD)","volume":"788","author":"Ara\u00fajo","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.phrs.2018.03.017","article-title":"Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1\/AMPK signaling pathway","volume":"131","author":"Yao","year":"2018","journal-title":"Pharmacol Res"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"e1801377","DOI":"10.1002\/mnfr.201801377","article-title":"Tomatidine reduces palmitate-induced lipid accumulation by activating AMPK via vitamin D receptor-mediated signaling in human HepG2 hepatocytes","volume":"63","author":"Kusu","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3892\/ijmm.2019.4059","article-title":"SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPAR\u03b1\/FoxO1 signaling pathway","volume":"43","author":"Zhang","year":"2019","journal-title":"Int J Mol Med"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.3892\/mmr.2017.7284","article-title":"Chinese herb extract improves liver steatosis by promoting the expression of high molecular weight adiponectin in NAFLD rats","volume":"16","author":"Liu","year":"2017","journal-title":"Mol Med Rep"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3892\/mmr.2020.11309","article-title":"Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway","volume":"22","author":"Zhang","year":"2020","journal-title":"Mol Med Rep"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.joim.2021.09.003","article-title":"Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis","volume":"19","author":"Shan","year":"2021","journal-title":"J Integr Med"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01300-0","article-title":"Restoration of HMGCS2-mediated ketogenesis alleviates tacrolimus-induced hepatic lipid metabolism disorder","author":"Li","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"35531","DOI":"10.1038\/srep35531","article-title":"LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL)","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-024-01278-w","article-title":"LncRNA MEG3 restrains hepatic lipogenesis via the FOXO1 signaling pathway in HepG2 cells","author":"Meng","year":"2024","journal-title":"Cell Biochem Biophys"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ijo.2015.173","article-title":"Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK","volume":"40","author":"Lee","year":"2016","journal-title":"Int J Obes"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.3390\/ijms19102932","article-title":"Fc gamma receptor IIb expressed in hepatocytes promotes lipid accumulation and gluconeogenesis","volume":"19","author":"Shu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1677\/JOE-07-0234","article-title":"Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet","volume":"194","author":"Barbuio","year":"2007","journal-title":"J Endocrinol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jfda.2018.01.005","article-title":"Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells","volume":"26","author":"Chen","year":"2018","journal-title":"J Food Drug Anal"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"3946320221137435","DOI":"10.1177\/03946320221137435","article-title":"Luteolin loaded on zinc oxide nanoparticles ameliorates non-alcoholic fatty liver disease associated with insulin resistance in diabetic rats via regulation of PI3K\/AKT\/FoxO1 pathway","volume":"36","author":"Ahmed","year":"2022","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"e1900728","DOI":"10.1002\/mnfr.201900728","article-title":"Vitamin D deficiency induces insulin resistance and re-supplementation attenuates hepatic glucose output via the PI3K-AKT-FOXO1 mediated pathway","volume":"64","author":"Mutt","year":"2020","journal-title":"Mol Nutr Food Res"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bbrc.2018.02.115","article-title":"SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation","volume":"498","author":"Pan","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13578-023-01119-y","article-title":"Menin orchestrates hepatic glucose and fatty acid uptake via deploying the cellular translocation of SIRT1 and PPAR\u03b3","volume":"13","author":"Liu","year":"2023","journal-title":"Cell Biosci"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s11010-022-04392-6","article-title":"Menin regulates lipid deposition in mouse hepatocytes via interacting with transcription factor FoxO1","volume":"477","author":"Wang","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"117776","DOI":"10.1016\/j.lfs.2020.117776","article-title":"Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factor","volume":"254","author":"Qi","year":"2020","journal-title":"Life Sci"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1743-7075-11-35","article-title":"Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice","volume":"11","author":"Zhu","year":"2014","journal-title":"Nutr Metab"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.arcmed.2017.11.016","article-title":"Regulation of SIRT3\/FOXO1 signaling pathway in rats with non-alcoholic steatohepatitis by Salvianolic acid B","volume":"48","author":"Wang","year":"2017","journal-title":"Arch Med Res"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"e23027","DOI":"10.1096\/fj.202201705RR","article-title":"Exogenous hydrogen sulfide alleviates hepatic endoplasmic reticulum stress via SIRT1\/FoxO1\/PCSK9 pathway in NAFLD","volume":"37","author":"Cui","year":"2023","journal-title":"FASEB J"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00394-013-0516-8","article-title":"Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1, and NF-kappa B pathways","volume":"53","author":"Xiao","year":"2014","journal-title":"Eur J Nutr"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/antiox10071076","article-title":"Green tea and epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): insights into the role of oxidative stress and antioxidant mechanism","volume":"10","author":"Tang","year":"2021","journal-title":"Antioxidants"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.pharep.2017.02.005","article-title":"Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway","volume":"69","author":"Pandey","year":"2017","journal-title":"Pharmacol Rep"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jcmgh.2020.10.006","article-title":"S100A11 promotes liver steatosis via FOXO1-mediated autophagy and lipogenesis","volume":"11","author":"Zhang","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"121145","DOI":"10.1016\/j.lfs.2022.121145","article-title":"The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1\/PPAR\u03b1\/GABARAPL1 signalling pathway","volume":"311","author":"Ramadan","year":"2022","journal-title":"Life Sci"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphys.2020.00177","article-title":"Protective properties of FOXO1 inhibition in a murine model of non-alcoholic fatty liver disease are associated with attenuation of ER stress and necroptosis","volume":"11","author":"Ding","year":"2020","journal-title":"Front Physiol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"e22316","DOI":"10.1096\/fj.202101345RRR","article-title":"Serpina3c deficiency induced necroptosis promotes non-alcoholic fatty liver disease through \u03b2-catenin\/Foxo1\/TLR4 signaling","volume":"36","author":"Qian","year":"2022","journal-title":"FASEB J"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.31050","article-title":"Lipotoxic hepatocyte-derived Exosomal MicroRNA 192-5p activates macrophages through Rictor\/Akt\/Forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41467-022-28692-z","article-title":"Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice","volume":"13","author":"Gao","year":"2022","journal-title":"Nat Commun"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"6254340","DOI":"10.1155\/2018\/6254340","article-title":"Enhancement of adiponectin ameliorates nonalcoholic fatty liver disease via inhibition of FoxO1 in type I diabetic rats","volume":"2018","author":"Xie","year":"2018","journal-title":"J Diabetes Res"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.2337\/db20-0437","article-title":"Muscular G9a regulates muscle-liver-fat Axis by Musclin under overnutrition in female mice","volume":"69","author":"Zhang","year":"2020","journal-title":"Diabetes"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"e7668","DOI":"10.7717\/peerj.7668","article-title":"FoxO1 is a critical regulator of hepatocyte lipid deposition in chronic stress mice","volume":"7","author":"Liu","year":"2019","journal-title":"PeerJ"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1042\/CS20170987","article-title":"Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?","volume":"131","author":"Gastaldelli","year":"2017","journal-title":"Clin Sci"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.cmet.2007.08.006","article-title":"Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver","volume":"6","author":"Matsumoto","year":"2007","journal-title":"Cell Metab"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"e0149344","DOI":"10.1371\/journal.pone.0149344","article-title":"SIRT1 disruption in human fetal hepatocytes leads to increased accumulation of glucose and lipids","volume":"11","author":"Tobita","year":"2016","journal-title":"PLoS One"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"44597","DOI":"10.1038\/srep44597","article-title":"FOXO transcription factors protect against the diet-induced fatty liver disease","volume":"7","author":"Pan","year":"2017","journal-title":"Sci Rep"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/HEP.0000000000000307","article-title":"p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1\/FOXO1\/IGF-1 signaling","volume":"78","author":"Kundu","year":"2023","journal-title":"Hepatology"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"e154333","DOI":"10.1172\/JCI154333","article-title":"Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis","volume":"132","author":"Lee","year":"2022","journal-title":"J Clin Invest"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1426780\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:33:30Z","timestamp":1719880410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1426780\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":110,"alternative-id":["10.3389\/fnut.2024.1426780"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2024.1426780","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"article-number":"1426780"}}